Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ C9orf41 Monoclonal Antibody (OTI6E4)
GREENER_CHOICE

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA525145

Catalog No. PIMA525145


Only null left
Add to Cart

Description

Description

C9orf41 Monoclonal Antibody for Western Blot, ICC/IF, IHC (P), Flow

N-methyltransferase that mediates the formation of anserine (beta-alanyl-N(Pi)-methyl-L-histidine) from carnosine. Anserine, a methylated derivative of carnosine (beta-alanyl-L-histidine), is an abundant constituent of vertebrate skeletal muscles. Also methylates other L-histidine-containing di- and tripeptides such as Gly-Gly-His, Gly-His and homocarnosine (GABA-His).
TRUSTED_SUSTAINABILITY
Specifications

Specifications

C9orf41
Monoclonal
0.91 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3
Q8N4J0
CARNMT1
Full length human recombinant protein of C9orf41 produced in HEK293T cell.
100 μL
Primary
Human
Antibody
IgG2a
Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry
OTI6E4
Unconjugated
CARNMT1
2410127L17Rik; Anserine-producing methyltransferase; C1H9orf41; C9orf41; CARNMT1; Carnosine N-methyltransferase; carnosine N-methyltransferase 1; RGD1311863; RIKEN cDNA 2410127L17 gene; similar to RIKEN cDNA 2410127L17; UPF0586; UPF0586 protein C9orf41; UPF0586 protein C9orf41 homolog
Mouse
Affinity chromatography
RUO
138199
-20°C, Avoid Freeze/Thaw Cycles
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.